Grant: Collaborative Research and Development Grants
McGill University
$235,252.00
Integration of Near-Infrared Spectroscopy-Based Process Analytical Technology with a Bench-Scale Continuous Manufacturing Process for an Omega-3 Phospholipid Pharmaceutical Product
EF 2020-21
Résumé
Current QC methods employed by pharmaceutical companies for quality assurance and process optimization of liquid-based pharmaceutical products entail the use of wet-chemical and chromatographic-based methods which are time consuming and can lead to reduced production efficiency. In some cases, the samples are sent to external labs that are equipped with advanced instrumentation which causes further delays in product release (up to 8-21 days). Accordingly, there is a need for pharmaceutical companies to implement online process analytical technologies to address the above drawbacks. Under an NSERC-Engage grant (2018), a Quebec-based pharmaceutical company initiated a collaborative study with Professor Ashraf Ismail (McGill University) to investigate the feasibility of implementing near-infrared spectroscopy to monitor the manufacturing process for an active pharmaceutical ingredient derived from krill oil. The outcome of the feasibility study was the development of preliminary near-infrared (NIR) spectroscopy-based calibration models for the determination of key components in the starting material and intermediates in the production process. Based on the positive outcome of the study, the company plans to expand its collaborative efforts with McGill University under the auspices of an NSERC-CRD grant to fully characterize the krill oil fractions, extracted during the manufacture of the final product (API), by both spectroscopic and mass-spectrometric techniques. The NSERC-CRD proposal also entails the development and validation of robust NIR calibration models for on-line monitoring at four key points in the continuous manufacturing process of the active pharmaceutical ingredient. This collaborative R&D initiative bring together team members from McGill and from a Québec-based pharmaceutical innovator who have the complementary expertise required to undertake this innovative implementation of NIR spectroscopy-based process analytical technology.
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
543888-2019
Name nom
Ismail, Ashraf
Department département
Food Science and Agricultural Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2019
Award amount
235252
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
515
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Instrumentation technology
Area of application fr
Technologie de l'instrumentation
Research subject code
3505
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Analytical spectroscopy
Research subject fr
Spectroscopie analytique
Installment
inst:2 - 2
Partie
1
Nb partie
2
Application title
Integration of Near-Infrared Spectroscopy-Based Process Analytical Technology with a Bench-Scale Continuous Manufacturing Process for an Omega-3 Phospholipid Pharmaceutical Product
Keyword
NSERC
Application summary
Current QC methods employed by pharmaceutical companies for quality assurance and process optimization of liquid-based pharmaceutical products entail the use of wet-chemical and chromatographic-based methods which are time consuming and can lead to reduced production efficiency. In some cases, the samples are sent to external labs that are equipped with advanced instrumentation which causes further delays in product release (up to 8-21 days). Accordingly, there is a need for pharmaceutical companies to implement online process analytical technologies to address the above drawbacks. Under an NSERC-Engage grant (2018), a Quebec-based pharmaceutical company initiated a collaborative study with Professor Ashraf Ismail (McGill University) to investigate the feasibility of implementing near-infrared spectroscopy to monitor the manufacturing process for an active pharmaceutical ingredient derived from krill oil. The outcome of the feasibility study was the development of preliminary near-infrared (NIR) spectroscopy-based calibration models for the determination of key components in the starting material and intermediates in the production process. Based on the positive outcome of the study, the company plans to expand its collaborative efforts with McGill University under the auspices of an NSERC-CRD grant to fully characterize the krill oil fractions, extracted during the manufacture of the final product (API), by both spectroscopic and mass-spectrometric techniques. The NSERC-CRD proposal also entails the development and validation of robust NIR calibration models for on-line monitoring at four key points in the continuous manufacturing process of the active pharmaceutical ingredient. This collaborative R&D initiative bring together team members from McGill and from a Québec-based pharmaceutical innovator who have the complementary expertise required to undertake this innovative implementation of NIR spectroscopy-based process analytical technology.